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Heat shock-mediated delayed protection against myocardial and cerebral ischemia 
has been attributed to induction of heat shock proteins (HSP), especially HSP70, in 
myocytes and neurons. However, heat shock preconditioning only induces HSP70 in 
endothelium. The purpose of this study was to examine the effect of heat shock on 
endothelium-dependent vasomotor tone. 
Isolated mouse aortas were heated to 43.5ºC for 15 min and returned to 37ºC for 18 
h. They were then mounted in a wire myograph to assess vasomotor responses to 
vasoconstrictors and vasodilatators. Intact heat shocked aortas showed reduction in 
phenylephrine- or 5-hydroxytryptamine-induced vasoconstriction, while no difference in 
vascular reactivity was detected in heat shocked endothelium-denuded aortas. Reduced 
vasoconstriction in heat shocked aortas was restored to control level by incubation with 
L-NAME, a nitric oxide synthase (NOS) inhibitor, but not by geldanamycin, a HSP90 
inhibitor. Furthermore, the effect of heat shock was not observed in aortas from eNOS 
null mice, suggesting that vasomotor responsiveness reduced by heat shock was related to 
increased basal eNOS activity. Immunoblot of lysates from heat shocked aortas did not 
show upregulation of eNOS or other NOS isoforms, while showing robust expression of 
HSP70; immunoprecipitation using eNOS polyclonal or monoclonal antibodies 
demonstrated HSP70 interaction with eNOS after heat shock. In enzymatic assay 
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(conversion of L-arginine to L-citrulline), HSP70 increased enzymatic activity of 
recombinant eNOS.  
We conclude that heat shock decreases vasomotor responses to vasoconstrictors by 
enhancing eNOS basal activity, through interaction with HSP70, that is robustly induced. 
Such an increase of eNOS might be related to protective effect of heat shock against 
ischemia reported in vivo. Finally, interaction between HSP70 and eNOS opens the 
intriguing possibility that HSP70 could have vasoregulatory properties in addition to its 
cytoprotective functions. 
 





Heat shock preconditioning enhances myocardial resistance against ischemia by reducing 
incidence of arrhythmias and infarct volume, as well as by improving post-ischemic 
contractile recovery [1, 2]. This protective effect closely correlates with the induction of a 
stress response characterized by de novo expression of the inducible 70-kD heat shock 
protein, HSP70 [3]. In addition to its protein chaperone activity, HSP70 has also shown clear 
cytoprotective properties in cultured myocytes, neurons and other cell types were it confers 
resistance to caspase-mediated (apoptotic) cell death [4, 5] and necrotic cell death induced by 
oxidative stress or simulated ischemia [6]. The protective potential of HSP70 against 
myocardial and cerebral ischemia has also been established in vivo using gene transfer [7] and 
transgenic mice [8-10]. Constitutive expression of either human or rat hsp70 gene reduces 
myocardial and cerebral ischemic injury and improves functional recovery [8-10]. From this 
evidence, it has been suggested that heat shock preconditioning in vivo induces HSP70 
accumulation in myocytes or neurons, thereby increasing cellular resistance to ischemic 
injury. This simple explanation has been challenged by reports demonstrating that heat shock 
preconditioning in vivo does not induce a stress response (measured by HSP70 expression) in 
myocytes [11] or neurons [12] but rather in endothelial cells [11]. These observations 
therefore suggest that additional protective mechanism(s) of heat shock preconditioning 
should be explored within the endothelium and endothelium-related functions. 
Besides heat shock preconditioning, induction of a stress response in blood vessels also 
occurs during balloon angioplasty [13] and in several pathophysiological conditions, such as 
stroke [14] or atherosclerosis [15, 16]. However, the precise impact of HSP70 and other 
stress-induced proteins to endothelial patho-physiology is still poorly understood.  
Nitric oxide production has a central role in ischemic preconditioning [17-19]. 
Furthermore, mice deficient in endothelial nitric oxide synthase (eNOS or NOS type III) [20] 
or rats treated with eNOS inhibitors [21] have larger cerebral infarctions when submitted to 
permanent occlusion of middle cerebral artery [20]. In contrast, increased endothelial NO 
production by upregulation of eNOS (by administration of statins, inhibitors of 3-hydroxy-3-
methylglutaryl-coenzyme A reductase, HMG-CoA) [22], or by enhanced eNOS activity (by 
infusion of eNOS substrate L-arginine [23, 24], reduces the cerebral area at risk after middle 
cerebral artery occlusion. A key step in eNOS activation relies on eNOS subcellular 
localization and interaction with scaffold/chaperone proteins, such as caveolins. Caveolins 
localize in membrane invaginations, called caveolae, forming cellular compartments enriched 
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with proteins involved in signal transduction. In endothelial cells, caveolin-1 binds to eNOS, 
preventing its interaction with calmodulin and its subsequent activation [25, 26]. Upon 
stimulation (either following acetylcholine treatment or shear stress), caveolin-1 inhibitory 
binding with eNOS is displaced by the 90-kDa heat shock protein (HSP90) which favors 
interaction with calmodulin and increases eNOS activity [27].  
Using isolated mouse aortas, here we examined the effect of induction of a stress 
response on endothelial function. More specifically, we investigated the effect of heat shock 
and heat shock proteins on NO-mediated vasomotor tone. We observed that heat shock 
preconditioning decreases the response to vasoconstrictor challenges, increases basal eNOS 







The animal protocols have been reviewed and approved by the Massachusetts General 
Hospital Committee on research, Subcommittee on research Animal Care (SRAC). All mice 
(6-8 week-old) used in this study had C57Bl/6J genetic background, including eNOS-/- mice 






Antibodies against heat shock proteins (HSP70 and HSP90) and recombinant human 
HSP70 were obtained from Stressgen Biotechnologies (Victoria, BC, Canada). Anti-NOS III 
(anti-eNOS) and anti-caveolin polyclonal antibodies were obtained from Transduction 
Laboratories (Lexington, NY, USA), anti-iNOS (anti-NOS II; sc-650) antibody from Santa 
Cruz Biotechnology (Santa Cruz, CA, USA) and anti-nNOS (anti-NOS I; 61-700) and anti-
eNOS (anti-NOS III monoclonal antibody; 33-4600) antibodies from Zymed (Oxnard, CA, 
USA). All additional reagents including phenylephrine, acetylcholine, N(G)-nitro-L-arginine 
methyl ester, sodium nitroprusside and geldanamycin were purchased from Sigma (St Louis, 
MO, USA).  
 
 
In Vitro Preparation and Heat Shock Treatment 
 
Mice were killed by decapitation. Aortas were removed and dissected under a binocular 
microscope into 1.5-2 mm long rings. Aortic rings were placed in 100µl phosphate buffered 
saline (PBS; pH 7.4) and incubated at room temperature, 42ºC or 43.5ºC for 15 min, using a 
PCR thermal cycler (PTC-200, MJ Research, Waltham, MA, USA). After treatment, rings 
were transferred to 5 ml DMEM supplemented with 10% fetal bovine serum and antibiotics 
and maintained 18 h in a humidified atmosphere of 5% CO2 at 37°C. After incubation, rings 
were rinsed in physiological solution before mounting in a wire myograph. 
Salvatore Salomone and Jean-Christophe Plumier 4 
Measurement of Contractile Tension in Isolated Aortas 
 
Aortic rings were immersed in physiological solution (composition, mM: NaCl, 118; 
KCl, 4.6; NaHCO3, 25; MgSO4, 1.2; KH2PO4, 1.2; CaCl2, 1.25; glucose, 10; EDTA, 0.025; 
pH 7.4 at 37°C), threaded onto stainless steel wires (40 µm diameter) and mounted in an 
isometric myograph (610M, Danish Myo Technology, Aarhus, Denmark) in physiological 
solution, maintained at 37°C and aerated with a gas mixture of 95% O2 - 5% CO2. After 
equilibration, the normalized passive resting force and the corresponding diameter were 
determined for each preparation from its own length-pressure curve, according to Mulvany 
and Halpern [28]. In this aim, the preparation was distended stepwise while recording 
micrometer reading and force. The stepwise distension was stopped when the effective 
transmural pressure exceeded 100 mm Hg (13.3 kPa). An exponential curve was then fitted to 
the internal circumference pressure data and the point of the curve corresponding to 100 mm 
Hg was determined (IC100). The preparation was then relaxed to a circumference equal to 0.9 
IC100 and held at this degree of stretch for the remainder of the experiment. Contractile 
responses were recorded into a computer, by using a data acquisition and recording software 
(Myodaq and Myodata, Danish Myo Technology). 
After normalization and 30-min equilibration in physiological solution, the preparations 
were stimulated with a 100 mM KCl-depolarizing solution (composition, mM: NaCl, 22.6; 
KCl, 98.8; NaHCO3, 25; MgSO4, 1.2; KH2PO4, 1.2; CaCl2, 1.25; glucose, 10; EDTA, 0.025, 
pH 7.4 at 37 °C). After washout and 30-min recovery, they were exposed to cumulative 
concentrations of phenylephrine (PE, 1 nM - 1 µM) followed by cumulative concentrations of 
acetylcholine (ACh, 1 nM -10 µM). After washout and recovery, rings were exposed to N(G)-
nitro-L-arginine methyl ester (L-NAME; 100 µM) and 30 min later to cumulative 
concentration of PE followed by cumulative concentration of sodium nitroprusside (SNP, 0.1 
nM - 1 µM). In some instances, rings were collected, opened and immersed in SDS-loading 
buffer for Western blot analysis. 
 
 
Removal of Endothelium 
 
To remove endothelium, anesthetized mice were perfused intracardially with 3 ml 
phosphate buffered saline (PBS; pH 7.4) followed by 1.5 ml of 0.03% Triton-X100 in water. 
Aortas were then removed and rings prepared. This treatment did not affect the maximal 
contractile response to PE, but abolished the relaxing response to 3 µM ACh.  
 
 
HUVEC Cell Cultures 
 
Human umbilical vein endothelial cells (HUVEC) were purchased from ATCC 
(Manassas, VA, USA) and cultured in M199 supplemented with 20% fetal bovine serum, 0.1 
mg/ml heparin, 0.03 mg/ml endothelial cell growth supplement (ECGS) on collagen-coated 
dishes (BD Biosciences, San Jose, Ca, USA). Heat shock was performed on exponentially 
growing cells by placing the culture dish in a 43.5ºC water bath for 15 min. After heat shock, 
cultured cells returned to their incubator for an additional 18 h before being harvested in 
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RIPA buffer (10 mM HEPES, pH 7.4, 0.1% CHAPS, 2 mM EDTA, 1 mM EGTA, 5 mM 
DTT, 1 mM PMSF, 10 µg/ml proteinase inhibitor cocktail).  
 
 
Western Blot Analysis 
 
Western blot analysis was performed using whole aortas lysed in RIPA buffer or single 
aortic rings collected in denaturing buffer. Lysates were centrifuged at 11,000 x g for 15 min 
at 4ºC. Protein concentration in supernatant was determined using Bio-Rad protein assay 
reagent (Bio-Rad Laboratories, Hercules, CA, USA). Proteins were denatured in SDS-
denaturing buffer (5M Tris, pH 6.8), 20% SDS, 20% glycerol, 1M β-mercaptoethanol), boiled 
for 2 min, separated using SDS-PAGE on 4-20% Tris-glycine gel (Invitrogen, Carlsbad, CA, 
USA) and transferred onto ImmobilonTM-P membranes (Millipore Corporation, Bedford, MA, 
USA). After blocking with 5% skim milk in Tris-buffered saline (TBS; 50 mMTris·HCl, 150 
mM NaCl) with 0.05% Tween 20 (Sigma), the membranes were incubated with primary 
antibody (see reagents). After incubation, membranes were washed in TBS-Tween and 
incubated with secondary antibodies (1:1,000; Amersham) for 1 h at room temperature. 
Detection was achieved using a chemiluminescence system (ECL system; Amersham, 
Buckinghamshire, UK) and exposing to Hyperfilm (Amersham). Equal loading of protein was 





Immunoprecipitation was performed according to Garcia-Gardena et al. [29]. The 
samples were placed in immunoprecipitation (IP) buffer (100mM Tris-HCl, pH 7.4, 1% v/v 
nonidet P-40; 10µl/ml proteinase inhibitor cocktail), homogenized on ice and centrifuged at 
12,000 × g for 10 min at 4ºC. Equal amounts of proteins were pre-cleaned by incubation with 
protein G-agarose and normal rabbit IgG for 2 h at 4°C, and then incubated with 2µg of anti-
eNOS polyclonal antibody (N30030; Transduction Laboratories) overnight. Protein 
complexes were then precipitated with protein G-agarose for 2 h at 4°C. The 
immunoprecipitants were washed 5 times in IP buffer, boiled 2 min in denaturing buffer, 
separated by 4-20% Tris-glycine SDS-PAGE and transferred to ImmobilonTM-P membrane. 
Membranes were then incubated with primary antibodies and processed as described above 





Data are presented as mean ± standard error of mean (SEM). Concentration-response 
curves were analyzed using two-way ANOVA. Difference between maximal contractions was 
analyzed using unpaired Student t-test or one-way ANOVA, followed by Tukey test. 
Statistical significance was set at P<0.05.  
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Results 
 
Induction of Stress Response in Isolated Mouse Aortas by Heat Shock 
 
In order to provide a better control for individual variability, we first established in vitro 
incubation of isolated mouse aortas; this allowed us to compare untreated vascular segments 
(control) versus segments in which the stress response (after heat shock) was induced; in this 
protocol the stress response was defined as a condition where heat shock induced a robust 
HSP70 expression, which was monitored in each experiment by western blot. In control (not 
subjected to heat shock) aortic rings, contractile responses to KCl-induced depolarization, 
phenylephrine, or acetylcholine were not changed by 18 h-incubation in culture medium (data 
not shown). Since incubation did not change physiological responses of isolated aortic rings, 
we used this in vitro model to examine the effect of heat shock on vasomotor function. Our in 
vitro approach offered the additional advantage of excluding possible confounding effects, 
observed after heat shock in vivo, such as heat stress-mediated activation of neuronal and/or 
hormonal axis. In a first series of experiments, aortic rings were subjected for 15 min to either 
42ºC or 43.5ºC. Eighteen hours later, the stress response induction and vasomotor function 
were examined (Figure 1). A 15-min exposure to 42ºC barely affected HSP70 expression in 
aortic rings, as revealed by Western blot analysis; in contrast, a robust induction of HSP70 
expression in isolated mouse aortas was obtained after treatment to 43.5ºC for 15 min (Figure 
1). Vasoconstriction induced by 1 µM phenylephrine (PE) was not different in 42ºC-heat 
shocked aortic rings and controls.  
 
 
Figure 1. Induction of a stress response as detected by HSP70 expression was accompanied by changes in 
vasomotor functions. Western blot analysis of HSP70 expression in 4 aortic rings incubated at 37ºC (Control, 
C), 42ºC (2 samples in middle lanes) or 43.5ºC. The bar graph shows comparison of 1µM phenylephrine 
(PE)-induced contractions between aortic rings incubated at 37ºC, 42ºC or 43.5ºC for 15 min, and then 
maintained in DMEM (with 10% FBS) for 18 h before physiological analysis. Each column represents the 
mean (±SEM, vertical bars) from 6-8 different rings. Notice the lack of change in PE-induced 
vasoconstriction following incubation at 42 °C, paralleled by lack of HSP70 induction as detected by western 
blot. **P<0.01 versus Control; one-way ANOVA and Tukey test. 
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Figure 2. Heat shock effect on vascular tone was mediated by endothelial nitric oxide synthase (eNOS). 
Active arterial wall tension, induced in vitro by cumulative concentrations of phenylephrine (A) or 5-
hydroxytryptamine (B), was reduced in heat-shocked (43.5 °C) mouse aortic rings compared to controls. In 
endothelium-denuded rings (C) and in rings from eNOS deficient mice (D) the effect of heat shock on 
phenylephrine-induced tone was not significant. Each curve represents the mean (± SEM, vertical bars) from 
8-12 different rings. **P<0.01 versus Control; two-way ANOVA. 
Conversely, exposure to 43.5ºC, which induced a stress response as detected by HSP70 
expression, was accompanied by significant decrease in vasoconstriction to either PE or 5-
hydroxytryptamine (5-HT, Figure 1 and 2 A, B). Therefore, 43.5ºC temperature was used as 
heat shock treatment throughout the experiments described. Contraction to 100 mM KCl was 
also reduced in heat shocked aortas compared to controls (2.54±0.12 mN/mm vs. 3.30±0.34 
mN/mm, respectively; p<0.05).  
 
 
Heat Shock Effect on Vascular Tone Was Mediated 
by Endothelial Nitric Oxide Synthase (eNOS) 
 
Basal (unstimulated) release of NO from endothelium modulates the responses of isolated 
vessels to vasoconstrictors, such as PE and 5-HT [30]. To assess if the decrease of contraction 
to PE after heat shock involved endothelial mechanisms, we tested some endothelium-
denuded isolated aortas (see also methods) in the same experimental paradigm.  
Control and heat shocked aortic rings without endothelium showed similar contraction to 
cumulative concentrations of PE (Figure 2 C), indicating that heat shock exerted its effect 
through endothelium. More detailed evidence was obtained using eNOS deficient mice, were 
Salvatore Salomone and Jean-Christophe Plumier 8 
heat shock did not change PE-induced contraction (Figure 2 D). Furthermore, the treatment 
with L-NAME, a NOS inhibitor, abolished the difference in PE-induced contraction between 
heat shocked and control aortas (Figure 3 A), suggesting that heat shock did not affect 
contractile function per se but rather increased basal NO production. In order to exclude the 
potential involvement of inducible NOS (iNOS or NOS II), we tested also aortas from iNOS 
null mice. These preparations responded to heat shock in a manner similar to aortas from wild 
type (Figure 3 C), ruling out iNOS as potential mediator of increased basal NO production in 
this system. 
Finally, because heat shocked and control aortas showed similar relaxation to the NO 
donor, sodium nitroprusside (Figure 3 D), we could exclude an effect of heat shock on 
signaling downstream to NO and/or in the ability of smooth muscle cells to relax in response 
to NO. Thus, these results indicated that heat shock treatment increased NO production in 
isolated aortas, through an increase of eNOS activity under basal conditions. 
 
 
Figure 3. Heat shock effect on vascular tone increased basal NO (was abolished by L-NAME), without 
changing sensitivity to exogenously added NO. Active arterial wall tension to 1µM phenylephrine, reduced in 
heat-shocked (43.5 °C) aortas from wild type mice (WT, A) or iNOS deficient mice (iNOS KO, C), was 
restored to control level by incubation with the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl 
ester (L-NAME; 100 µM). Notice, in (B), the absence of effect of heat shock and/or L-NAME in rings from 
eNOS deficient mice. In (D), concentration-dilatation curves to cumulative concentrations of the NO-donor 
sodium nitroprusside, in control and heat-shocked rings from control wild type mice. Each column or curve 
represents the mean (± SEM, vertical bars) from 8-12 different rings. **P<0.01 versus Control; one-way 
ANOVA and Tukey test. 
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Stress Response Induction Increased the 
Expression of Heat Shock Proteins but Not of 
Nitric Oxide Synthase Isoforms 
 
Both HSP90 and HSP70 were constitutively expressed in aortas as shown by Western 
blot analysis. After heat shock, HSP90 was slightly increased (Figure 4) while HSP70 
expression was markedly increased (Figure 1). We also examined whether heat shock altered 
the expression of caveolin-1, a protein exhibiting an inhibitory interaction with endothelial 
NOS [25, 29]. Western blot analysis revealed that caveolin-1 was unchanged after heat shock 
in isolated aortas (not shown). The effect of heat shock on expression of NOS isoforms was 
also examined by Western blot analysis (Figure 4). Neuronal NOS (nNOS, NOS type I) or 
inducible NOS (iNOS, NOS type II) were barely detected in control aortas and did not 
increase in heat shocked aortas. Finally and more importantly, eNOS expression was not 
increased after heat shock (Figure 4). These data therefore showed that increased basal NO 
production after heat shock could not be explained by an increased expression of any NOS 
isoform (including non-endothelial isoforms). 
 
 
Inhibition of HSP90 Did Not Inhibit the Effect of 
Heat Shock on Phenylephrine-Induced 
Vasoconstriction 
 
Under stimulated conditions, i.e. when challenging with endothelium-dependent 
vasodilators, HSP90 has an activator effect on eNOS activity, which can be blocked by 
geldanamycin, an inhibitor of HSP90 [27]. To determine whether or not the increase in 
HSP90 observed after heat shock (Figure 4) was related to endothelium-dependent inhibiton 
of vasoconstriction to PE, we challenged some aortic rings with geldanamycin (20 µM).  
 
 
Figure 4. Induction of a stress response increased expression of heat shock proteins (HSP) without changing 
the expression of any NOS isoform.Western blot analysis for nitric oxide synthase isoforms was carried out 
in control (C) and heat-shocked (43.5 °C) aortic rings. Expression of neuronal NOS or NOS I (nNOS), 
inducible NOS or NOS II (iNOS) and endothelial NOS or NOS III (eNOS) were not increased by heat shock. 
Because nNOS and iNOS were barely detectable in mouse aorta, mouse hippocampus (Hip) and LPS-treated 
mouse microglial N11 cells (LPS) were run as positive controls for nNOS and iNOS, respectively. 
Expression of 90 kD heat shock protein (HSP90) was increased by heat shock, as expected. 
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Figure 5. Inhibition of HSP90 did not inhibit the effect of heat shock on phenylephrine-induced 
vasoconstriction. Typical experiment repeated three times with similar results. Cumulative concentrations (1 
nM -1 µM) of phenylephrine (PE) followed by ACh, were added to the organ chamber by half log increase, 
as indicated by black dots on the tracing. After a first run, preparations were washed and allowed to recover 
for 30 min, incubated with 100 µM L-NAME, and challenged again with 1 µM PE. Upper trace, Control; 
middle trace heat-shock; lower trace heat-shock + 20 µM geldanamycin (HSP90 inhibitor). Notice that the 
contractile response evoked by PE in the absence of L-NAME is depressed by heat shock, regardless of 
geldanamycin-treatment (as further demonstrated by the increase in contraction with L-NAME, in both 
middle and lower traces). In contrast, relaxation to ACh is abolished by geldanamycin but is unaffected by 
heat shock. 
As expected [27], geldanamycin blocked acetylcholine(ACh)-induced relaxation, 
indicating that inhibition of HSP90 and thereby of ACh-stimulated eNOS activity, effectively 
occurred in our system (Figure 5); however, geldanamycin failed to restore the contractile 
response to PE in heat shocked aortic rings, indicating that increased basal NO production 
was unrelated to HSP90, while L-NAME was able to restore PE-induced maximal contraction 
in heat shocked aortas, in a similar manner, with or without geldanamycin (Figure 5). 
 
 
HSP70 Interacts with eNOS after Heat Shock 
 
Protein-protein interaction between eNOS and the inducible HSP70 was examined in 
isolated aortas after heat shock using immunoprecipitation with anti-eNOS polyclonal 
antibody (Figure 6). HSP70 was detected in eNOS- immunoprecipitants from heat shocked 
aortas but not from controls, although there was constitutive HSP70 expression in isolated 
Heat shock, HSP70and eNOS 11 
aortas without heat shock treatment (Figure 1). Similar results were also observed in eNOS-
immunoprecipitants from heat shocked HUVEC using either monoclonal or polyclonal anti-
eNOS antibodies (not shown). In addition, eNOS expression was similar in control and heat 
shocked aortas (Figure 6), while HSP90 was not co-immunoprecipitated with eNOS, either in 
control or heat shocked aortic rings (not shown). 
HSP70-eNOS in vitro interaction was further examined by measuring eNOS enzymatic 
activity as conversion of L-arginine to L-citrulline. As shown in Figure 7, addition of 
recombinant human HSP70 to recombinant bovine eNOS significantly increased eNOS 
enzymatic activity, which was strongly inhibited when L-NAME had been included in the 





Induction of heat shock proteins, especially HSP70, in blood vessels is a relatively 
common phenomenon observed in various experimental models and in some 
pathophysiological conditions [31, 32]. Induction of HSP70 in vascular endothelium occurs 
following heat shock preconditioning, suggesting a central role of blood vessels in heat 
shock-mediated protection against myocardial ischemia [11]. In this report, we show that heat 
shock preconditioning modified blood vessel physiology and endothelial function. More 
specifically, heat shock reduced blood vessel vasoconstriction to various stimuli (high K+-
induced depolarization, 5-hydroxytryptamine, phenylephrine) by increasing eNOS activity 
under basal conditions, via a mechanism independent of HSP90. The other potential candidate 
as modulator of eNOS activity was HSP70, because we found that it was strongly induced by 
heat shock in our system. In this respect, we showed, by immunoprecipitation, that eNOS and 
HSP70 interacted in heat shocked aortas or HUVEC, and confirmed, in a cell-free assay, that 
HSP70 can increase eNOS enzymatic activity. These observations indicate that HSP70 
interacts with eNOS and increases its enzymatic activity, opening new therapeutic targets 
which could be relevant in pathological conditions such as myocardial infarction and stroke. 
 
 
Figure 6. Interaction between HSP70 and eNOS in vascular endothelium. Typical experiment repeated three 
times with similar results. Protein lysates (120 µg) from control (C) and heat shocked (43.5°C) mouse aorta 
were immunoprecipitated using eNOS polyclonal antibody and further analyzed by SDS-PAGE and Western 
blot, using HSP70 antibody. The same membrane was rinsed and probed again using a specific eNOS 
monoclonal antibody to show equal amount of eNOS in both lysates. Similar results were obtained by 
immunoprecipitation of lysates from heat shocked HUVEC.  
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Figure 7. Interaction between HSP70 and eNOS in a cell free system. Recombinant bovine eNOS was 
incubated in Tris buffer with various amount of recombinant human HSP70 in absence or presence of L-
NAME. After 15 min incubation, NOS activity was determined by measuring conversion of L-arginine to L-
citrulline. Each column represent the mean (± SEM, vertical bars) from two different experiments, each 
performed in triplicate. **P<0.01 versus HSP70 0, ††P<0.01 versus HSP70 60 pmol; one-way ANOVAand 
Tukey test. 
The in vitro induction of the stress response in aortic segments, as defined by HSP70 
expression, occurred after heat shock at 43.5 °C in our system, but not after heat shock at 42 
°C. This is consistent with induction of a stress response in cultured endothelial cells where 
HSP70 expression and cell resistance to injury have been observed after exposure to 43ºC for 
1.5 h [33]. In contrast, in vivo, a single hyperthermic episode at 42ºC for 15 min may be 
sufficient to induce an endothelial stress response measured by HSP70 expression [11, 34], 
suggesting that additional factors in vivo contribute to lower the threshold for induction of a 
stress response. 
Our data show that the reduction of contractile responses induced by heat shock was 
caused by increased NO production, but was not due to higher expression of NOS isoforms, 
in particular of eNOS, as detected by western blotting. Therefore, heat shock preconditioning 
differs from other treatments, such as endotoxic shock and LPS-treatment, (that induce iNOS 
gene expression) [35], or statin administration (that stabilizes eNOS mRNA) [36], because it 
increases NO production in blood vessels without changing the abundance of eNOS or iNOS. 
The fact that heat shock-induced vasomotor changes required the presence of endothelium 
and were absent in eNOS deficient mice, indicates that heat shock acted through a 
modification of eNOS enzymatic activity. 
Interestingly, in our system, heat shock increased basal eNOS activity without changing 
eNOS activity stimulated by ACh, at variance with the effect of the activator protein HSP90, 
which has been shown to interact with eNOS following agonist-stimulated endothelium-
dependent vasodilation [27]. Although HSP90 was slightly increased by heat shock in our 
system, three arguments indicate that heat shock-increased basal eNOS activity did not 
involve HSP90. Firstly, agonist (ACh)-mediated relaxation in heat shocked aortas was not 
increased but, rather, it was reduced (not shown). This effect is opposite to that reported in 
HSP90-transfected endothelial cells [27]. Secondly, inhibition of HSP90 (using a specific 
HSP90 inhibitor, geldanamycin) did not restore contractility in heat shocked aortas while still 
blocking ACh-mediated relaxation, confirming that HSP90 regulates eNOS upon agonist 
stimulation but not basal eNOS activity [27]. Finally, HSP90 only barely co-
immunoprecipitated with eNOS in control or heat shocked aortas (not shown), confirming 
other reports where HSP90-eNOS interaction, drastically increased after agonist stimulation, 
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was barely detectable under basal conditions [27, 37]. From these results, it appeared that heat 
shock enhanced eNOS activity via a mechanism independent of HSP90.  
Another mechanism reported to increase basal eNOS activity involves downregulation of 
caveolin [38]. However, when probing for caveolin-1, we found that heat shock did not 
modify the total amount of caveolin-1 in isolated aortas (not shown). Since heat shock has 
been reported to acutely modify caveolin localization in cultured mouse NIH3T3 fibroblasts 
and to induce internalization of caveolin followed by a rapid (within 4 h) return to plasma 
membrane [39], it is also possible that long-term effects could take place after heat shock and 
account for increased eNOS basal activity. Further investigations are needed to clarify the 
role of caveolin and caveolin-eNOS interaction after heat shock preconditioning. 
We showed that HSP70 co-immunoprecipitated with eNOS in mouse aortas and HUVEC. 
Although reverse immunoprecipitation experiment (detection of eNOS in immunoprecipitated 
proteins using HSP70 antibody) was not feasible due to high amount of proteins competing 
for HSP70 binding after heat shock preconditioning, we observed HSP70-eNOS interaction in 
various paradigms (cell culture or cell-free assay), in different species (mouse and human) 
and using monoclonal or polyclonal anti-eNOS antibodies, which strengthens the observation 
in isolated blood vessels. Furthermore, addition of recombinant HSP70 could increase 
eNOSactivity in a cell-free assay, indicating that HSP70-eNOS interaction may have a 
functional outcome.  
Obviously HSP70 is known to chaperone denatured proteins after treatment with elevated 
temperatures, which helps in guiding their refolding and/or triage to the proteasome [40]. In 
our system, however, eNOS did not appear to be denatured, as indicated by a maintained 
ACh-mediated relaxation in mouse aortas immediately or 5 h after heat shock (not shown). 
Moreover, one would not expect a recovered activity to be significantly increased compared 
to initial conditions. It seems more likely that HSP70 interacts with native eNOS. We propose 
that after heat shock, HSP70-binding domains are exposed due to post-translational 
modifications of eNOS or removal of masking protein(s). Indeed, HSP70 is able to interact 
with co-chaperones, such as CHIP (carboxyl terminus of Hsp70-interacting protein), which 
regulates eNOS activity and trafficking between subcellular compartments [41]. Further 
experiments are needed to determine the precise molecular mechanism through which HSP70 
modulates eNOS activity following heat shock preconditioning. 
Our data cannot rule out that additional mechanisms regulating eNOS activity, such as 
fatty acylation or phosphorylation of eNOS or substrate/co-factor availability, could also 
contribute to heat shock-mediated effects. Analyses of eNOS phosphorylation state, eNOS 
subcellular localization and in vitro NOS activity will help in clarifying these issues. 
Preliminary experiments revealed that heat shock did not increase the amount of Akt or 
phophorylated isoforms of Akt (not shown), a kinases that phosphorylates eNOS and 
increases its activity [42].  
Our findings are important for several reasons. Firstly, we provide a mechanistic basis to 
explain heat shock (and HSP70) protective effect in vivo against myocardial and cerebral 
ischemia. Indeed, increase in basal endothelial NO production enhances blood supply to 
ischemic tissue as shown after eNOS upregulation, and results in decreased infarct size [24]. 
Similarly, NO increase could also provide explanation for heat shock-mediated prevention of 
leukocyte adherence after ischemia/reperfusion injury [43].  
Secondly, we showed that HSP70 interacts with eNOS under stressful conditions, but it is 
likely that similar interactions also occurs in pathological conditions known to induce HSP70 
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synthesis in endothelial cells and blood vessels. For example, endothelial cells overexpress 
HSP70 in response to exposure to oxidized LDL [16] and HSP70 has been observed in 
atherosclerotic human arteries [44] or aortas after physiological stress [45]. Our data provide 
evidence that HSP70 interacts with eNOS and could thereby modify eNOS function, giving a 
new perspective to previous observations.  
Thirdly, regulation of NO production by endothelium is of paramount importance in 
pathological conditions such as stroke, atherosclerosis, hypertension to mention a few. For 
example, stroke prevention favors treatments with statins that increase basal eNOS activity. 
Here we observed that heat shock preconditioning also increase basal eNOS activity without 
eNOSupregulation, suggesting that alternative (and may be synergistic) mechanisms may be 
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